First Time Loading...

Swedish Orphan Biovitrum AB (publ)
STO:SOBI

Watchlist Manager
Swedish Orphan Biovitrum AB (publ) Logo
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Watchlist
Price: 270 SEK -0.81% Market Closed
Updated: Jun 16, 2024
Have any thoughts about
Swedish Orphan Biovitrum AB (publ)?
Write Note

Swedish Orphan Biovitrum AB (publ)
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Swedish Orphan Biovitrum AB (publ)
Capital Expenditures Peer Comparison

Comparables:
BIOG B
HNSA
BONEX
VITR
BIOA B

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Capital Expenditures
-kr2.4B
CAGR 3-Years
15%
CAGR 5-Years
24%
CAGR 10-Years
-49%
Biogaia AB
STO:BIOG B
Capital Expenditures
-kr48.6m
CAGR 3-Years
-45%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Hansa Biopharma AB
STO:HNSA
Capital Expenditures
kr134k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Capital Expenditures
-kr7.6m
CAGR 3-Years
-57%
CAGR 5-Years
-64%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Capital Expenditures
-kr134m
CAGR 3-Years
-77%
CAGR 5-Years
-72%
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Capital Expenditures
-kr7.4m
CAGR 3-Years
16%
CAGR 5-Years
-12%
CAGR 10-Years
N/A

See Also

What is Swedish Orphan Biovitrum AB (publ)'s Capital Expenditures?
Capital Expenditures
-2.4B SEK

Based on the financial report for Mar 31, 2024, Swedish Orphan Biovitrum AB (publ)'s Capital Expenditures amounts to -2.4B SEK.

What is Swedish Orphan Biovitrum AB (publ)'s Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-49%

Over the last year, the Capital Expenditures growth was 47%. The average annual Capital Expenditures growth rates for Swedish Orphan Biovitrum AB (publ) have been 15% over the past three years , 24% over the past five years , and -49% over the past ten years .